Penn spinout iECURE, inc., co-founded by Dr. James Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director’s Professor at Penn Medicine, was chosen as one of Fierce Biotech’s 2024 Fierce 15. This list includes 15 companies that are breaking barriers and defining the future of the biotechnology industry.
iECURE was recognized for its innovative approach to treating rare childhood diseases by developing therapies that correct gene function directly inside the body. The honor comes just weeks after iECURE was named one of PHL Inno’s 2024 Fire Awards honorees. Read more about iECURE and the Fierce 15 list here.